Fidelity Investments’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,659
| Closed | -$54.1K | – | 5327 |
|
|
2025
Q1 | $54.1K | Sell |
5,659
-11,907
| -68% | -$156K | ﹤0.01% | 3833 |
|
|
2024
Q4 | $277K | Buy |
17,566
+1,711
| +11% | +$27.5K | ﹤0.01% | 3144 |
|
|
2024
Q3 | $240K | Buy |
15,855
+3,635
| +30% | +$55.3K | ﹤0.01% | 3133 |
|
|
2024
Q2 | $168K | Buy |
12,220
+902
| +8% | +$12.9K | ﹤0.01% | 3091 |
|
|
2024
Q1 | $151K | Sell |
11,318
-43
| -0.4% | -$501 | ﹤0.01% | 3127 |
|
|
2023
Q4 | $112K | Sell |
11,361
-48
| -0.4% | -$456 | ﹤0.01% | 3174 |
|
|
2023
Q3 | $121K | Sell |
11,409
-301
| -3% | -$3.63K | ﹤0.01% | 3039 |
|
|
2023
Q2 | $162K | Sell |
11,710
-1,432
| -11% | -$17.6K | ﹤0.01% | 3008 |
|
|
2023
Q1 | $133K | Buy |
13,142
+936
| +8% | +$15.8K | ﹤0.01% | 3103 |
|
|
2022
Q4 | $190K | Buy |
12,206
+845
| +7% | +$14.4K | ﹤0.01% | 3023 |
|
|
2022
Q3 | $224K | Hold |
11,361
| – | – | ﹤0.01% | 3019 |
|
|
2022
Q2 | $286K | Hold |
11,361
| – | – | ﹤0.01% | 3028 |
|
|
2022
Q1 | $281K | Buy |
11,361
+11,257
| +10,824% | +$242K | ﹤0.01% | 3166 |
|
|
2021
Q4 | $3K | Buy |
104
+62
| +148% | +$2.03K | ﹤0.01% | 3901 |
|
|
2021
Q3 | $2K | Hold |
42
| – | – | ﹤0.01% | 3975 |
|
|
2021
Q2 | $2K | Hold |
42
| – | – | ﹤0.01% | 3892 |
|
|
2021
Q1 | $2K | Hold |
42
| – | – | ﹤0.01% | 3696 |
|
|
2020
Q4 | $3K | Sell |
42
-16,270
| -100% | -$1.91M | ﹤0.01% | 3507 |
|
|
2020
Q3 | $3.22M | Sell |
16,312
-10,525
| -39% | -$2.65M | ﹤0.01% | 2188 |
|
|
2020
Q2 | $7.51M | Sell |
26,837
-21,357
| -44% | -$4.98M | ﹤0.01% | 1916 |
|
|
2020
Q1 | $8.58M | Sell |
48,194
-11,574
| -19% | -$2.48M | ﹤0.01% | 1735 |
|
|
2019
Q4 | $14.7M | Buy |
59,768
+45,827
| +329% | +$8.44M | ﹤0.01% | 1714 |
|
|
2019
Q3 | $1.65M | Sell |
13,941
-94
| -0.7% | -$14.2K | ﹤0.01% | 2316 |
|
|
2019
Q2 | $2.27M | Sell |
14,035
-23,108
| -62% | -$4.39M | ﹤0.01% | 2295 |
|
|
2019
Q1 | $8.78M | Buy |
37,143
+223
| +0.6% | +$56.5K | ﹤0.01% | 1906 |
|
|
2018
Q4 | $10M | Buy |
36,920
+21,278
| +136% | +$6.16M | ﹤0.01% | 1807 |
|
|
2018
Q3 | $6.97M | Buy |
15,642
+8,884
| +131% | +$4.16M | ﹤0.01% | 2049 |
|
|
2018
Q2 | $3.18M | Buy |
+6,758
| New | +$3.57M | ﹤0.01% | 2258 |
|
|
2016
Q1 | – | Sell |
-16,425
| Closed | -$1.48M | – | 2664 |
|
|
2015
Q4 | $1.48M | Sell |
16,425
-1,083
| -6% | -$118K | ﹤0.01% | 2472 |
|
|
2015
Q3 | $2.01M | Sell |
17,508
-50
| -0.3% | -$8.79K | ﹤0.01% | 2419 |
|
|
2015
Q2 | $4.06M | Buy |
17,558
+9,225
| +111% | +$1.78M | ﹤0.01% | 2294 |
|
|
2015
Q1 | $1.32M | Hold |
8,333
| – | – | ﹤0.01% | 2487 |
|
|
2014
Q4 | $786K | Buy |
8,333
+1,447
| +21% | +$143K | ﹤0.01% | 2579 |
|
|
2014
Q3 | $677K | Buy |
+6,886
| New | +$611K | ﹤0.01% | 2589 |
|
Other funds holding ASMB
GS
BGI
MCM
Fidelity Investments's ASMB Position: Q2 2025 in Review
Fidelity Investments sold out of Assembly Biosciences (ASMB) in Q2 2025, closing a stake of 5,659 shares — an estimated $54.1K sold.
Fidelity Investments first reported a position in ASMB in Q3 2014 and held it in 34 quarters. The position peaked at $14.7M in Q4 2019. 33 funds tracked by Wall St. Rank hold ASMB as of Q2 2025.
- Fidelity Investments reported no remaining Assembly Biosciences position as of Q2 2025 after selling out during the quarter.
- Fidelity Investments sold 5,659 Assembly Biosciences shares in Q2 2025, an estimated $54.1K.
- Fidelity Investments first reported a position in Assembly Biosciences in Q3 2014 and held it in 34 quarters.
- Fidelity Investments's Assembly Biosciences position peaked at $14.7M in Q4 2019.
- 33 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2025.
Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.